Drug profile · INN
eltrombopag
REVOLADE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
eltrombopag (REVOLADE) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN eltrombopag
Brand REVOLADE
Route ORAL
Formulation TABLET
ATC code B02BX05
Originator Novartis Pharmaceuticals
Frequently asked questions
What is eltrombopag?
eltrombopag (REVOLADE) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for eltrombopag?
REVOLADE is a marketed brand name for eltrombopag. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eltrombopag?
eltrombopag has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.